BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 2406802)

  • 21. Raynaud's phenomenon in mixed connective tissue disease.
    Grader-Beck T; Wigley FM
    Rheum Dis Clin North Am; 2005 Aug; 31(3):465-81, vi. PubMed ID: 16084319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early undifferentiated connective tissue disease. V. An inception cohort 5 years later: disease remissions and changes in diagnoses in well established and undifferentiated connective tissue diseases.
    Williams HJ; Alarcón GS; Neuner R; Steen VD; Bulpitt K; Clegg DO; Ziminski CM; Luggen ME; Polisson RP; Willkens RF; Yarboro C; Morgan J; Egger MJ; Ward JR
    J Rheumatol; 1998 Feb; 25(2):261-8. PubMed ID: 9489817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Capillaroscopy.
    Cutolo M; Pizzorni C; Secchi ME; Sulli A
    Best Pract Res Clin Rheumatol; 2008 Dec; 22(6):1093-108. PubMed ID: 19041079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Raynaud phenomenon in childhood: review and progress control in eight cases].
    González Pascual E; Esquinas Rychen G; Ruiz España A; Ros Viladoms JB; Juanola Roura X
    An Esp Pediatr; 1998 Jun; 48(6):603-7. PubMed ID: 9662844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Capillaroscopy.
    Cutolo M; Pizzorni C; Sulli A
    Best Pract Res Clin Rheumatol; 2005 Jun; 19(3):437-52. PubMed ID: 15939368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon identified by diagnosis of an associated disease: results of ten years of prospective surveillance.
    Hirschl M; Hirschl K; Lenz M; Katzenschlager R; Hutter HP; Kundi M
    Arthritis Rheum; 2006 Jun; 54(6):1974-81. PubMed ID: 16732585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic model based on nailfold capillaroscopy for identifying Raynaud's phenomenon patients at high risk for the development of a scleroderma spectrum disorder: PRINCE (prognostic index for nailfold capillaroscopic examination).
    Ingegnoli F; Boracchi P; Gualtierotti R; Lubatti C; Meani L; Zahalkova L; Zeni S; Fantini F
    Arthritis Rheum; 2008 Jul; 58(7):2174-82. PubMed ID: 18576359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases. A future tool for the analysis of microvascular heart involvement?
    Cutolo M; Sulli A; Secchi ME; Paolino S; Pizzorni C
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 4():iv43-6. PubMed ID: 16980724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Raynaud's phenomenon: clinical spectrum of 118 patients.
    De Angelis R; Del Medico P; Blasetti P; Cervini C
    Clin Rheumatol; 2003 Oct; 22(4-5):279-84. PubMed ID: 14576990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum autoantibodies profile and increased levels of circulating intercellular adhesion molecule-1: a reflection of the immunologically mediated systemic vasculopathy in rheumatic diseases?
    Kuryliszyn-Moskal A; Klimiuk PA; Sierakowski S
    Arch Immunol Ther Exp (Warsz); 2001; 49(6):423-30. PubMed ID: 11814236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Indications for nailbed capillaroscopy in Raynaud's phenomenon].
    Chamot AM; Monti M
    Schweiz Med Wochenschr; 1985 Dec; 115(51):1852-7. PubMed ID: 4089584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Capillary microscopy of the nail fold in Raynaud's phenomenon. Use in the early diagnosis of scleroderma].
    Rivera Redondo J; López Bote JP; Alvaro-Gracia Alvaro JM; Sabando Suárez P; Ossorio Castellanos C
    Rev Clin Esp; 1985 Jun; 177(1):7-10. PubMed ID: 4035042
    [No Abstract]   [Full Text] [Related]  

  • 34. Digital blood flow and nailfold capillary microscopy in Raynaud's phenomenon.
    Lee P; Sarkozi J; Bookman AA; Keystone EC; Armstrong SK
    J Rheumatol; 1986 Jun; 13(3):564-9. PubMed ID: 3735278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of microvascular pericytes in autoimmune Raynaud's phenomenon and systemic sclerosis.
    Rajkumar VS; Sundberg C; Abraham DJ; Rubin K; Black CM
    Arthritis Rheum; 1999 May; 42(5):930-41. PubMed ID: 10323448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnostic contribution and current concepts in nailfold capillary microscopy in rheumatology].
    Caleiro MT
    Rev Hosp Clin Fac Med Sao Paulo; 1997; 52(2):104-10. PubMed ID: 9435405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Raynaud's phenomenon.
    Hughes M; Herrick AL
    Best Pract Res Clin Rheumatol; 2016 Feb; 30(1):112-32. PubMed ID: 27421220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical analysis of 79 pulmonary arterial hypertension cases from 1892 connective tissue disease patients].
    Lei YX; Zhang X; Cui Y; Dong GF; Luo RQ
    Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(41):2934-7. PubMed ID: 20137654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The diagnostic value of clinical signs and symptoms in patients with Raynaud's phenomenon. A cross-sectional study.
    Wollersheim H; Thien T
    Neth J Med; 1990 Dec; 37(5-6):171-82. PubMed ID: 2074908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases.
    Rychlik-Golema W; Mastej K; Adamiec R
    Int Angiol; 2006 Jun; 25(2):221-7. PubMed ID: 16763543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.